Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder Tumors
19761.3k citationsÁlvaro Morales, David Eidinger et al.The Journal of Urologyprofile →
Intracavitary Bacillus Calmette-Guerin in the Treatment of Superficial Bladder Tumors
2016569 citationsÁlvaro Morales, David Eidinger et al.The Journal of Urologyprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by David Eidinger
Since
Specialization
Citations
This map shows the geographic impact of David Eidinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Eidinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Eidinger more than expected).
This network shows the impact of papers produced by David Eidinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Eidinger. The network helps show where David Eidinger may publish in the future.
Co-authorship network of co-authors of David Eidinger
This figure shows the co-authorship network connecting the top 25 collaborators of David Eidinger.
A scholar is included among the top collaborators of David Eidinger based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with David Eidinger. David Eidinger is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Eidinger, David, et al.. (1979). Heterotoxicity of human serum. IV. Role of the alternative complement pathway and natural antibody in the lethal toxicity of human serum for mice.. PubMed. 60(4). 414–26.2 indexed citations
3.
Eidinger, David & Álvaro J. Ruiz. (1978). BCG immunotherapy of metastatic adenocarcinoma of the kidney.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 339–41.8 indexed citations
Mates, A, et al.. (1976). The heterocytotoxicity of human serum. III. Studies of the serum levels and distribution of activity in human populations.. PubMed. 26(3). 601–8.6 indexed citations
7.
Pross, Hugh F. & David Eidinger. (1973). In vitro studies of 'antigenic competition'. II. Reconstitution of the immune defect and the relationship between antigen-induced suppression and non-specific enhancement.. PubMed. 25(2). 269–81.4 indexed citations
8.
Eidinger, David, et al.. (1973). Further studies of thymus-bone marrow cell synergism in cutaneous manifestations of delayed hypersensitivity to methylated human serum albumin. The effect of cortisone acetate.. PubMed. 24(5). 813–22.3 indexed citations
Eidinger, David. (1968). The immune response to sheep erythrocytes in the mouse. II. A study of the cytological events in the draining lymph node utilizing cellular imprints.. PubMed. 15(3). 357–69.7 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.